Skip to main content
. 2017 Sep 1;2017:6210694. doi: 10.1155/2017/6210694

Figure 10.

Figure 10

Sal A modulates CYLD via PI3K/AKT/mTOR pathway. (a) Our former study proved that Sal A promoted ERK and PI3K/AKT/mTOR phosphorylation in ARPE-19 cells after 48 hours. (b) Western blot results of CYLD showing that PI3k and mTOR inhibitor abolished Sal A-induced CYLD downregulation. (c) Quantitative densitometry results of western blot. Data are expressed as means ± ESM. P < 0.05 versus the control and OX-LDL + Sal A group.